Exagen (XGN) Income towards Parent Company (2018 - 2026)
Exagen's (XGN) quarterly Income towards Parent Company came in at -$4.0 million in Q1 2026, down 5.73% YoY from -$4.2 million in Q1 2025, and up 15.11% on a QoQ basis from -$4.7 million in Q4 2025.
Exagen (XGN) Income towards Parent Company (2018 - 2026) Analysis & Trends
Exagen (XGN) has 9 years of Income towards Parent Company data on file, last reported at -$4.0 million in Q1 2026.
- Quarterly Income towards Parent Company fell 5.73% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.2 million (down 30.04% YoY) and the FY2025 annual result came in at -$20.0 million, down 31.99% from the prior year.
- Income towards Parent Company rose to -$4.0 million in Q1 2026, from -$4.7 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$3.0 million in Q2 2024 to a low of -$17.3 million in Q1 2022.
- A 5-year average of -$7.1 million and a median of -$5.0 million in 2024 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 179.03% — and 2023, when it soared 69.94%.
- Tracing XGN's Income towards Parent Company over 5 years: stood at -$14.4 million in 2022, then jumped by 62.68% to -$5.4 million in 2023, then jumped by 30.03% to -$3.8 million in 2024, then retreated by 24.25% to -$4.7 million in 2025, then climbed by 15.11% to -$4.0 million in 2026.
- The last three Income towards Parent Company figures came in at -$4.0 million (Q1 2026), -$4.7 million (Q4 2025), and -$7.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Exagen | 158.28 Mn | 133.68 Mn | 12.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.20 Mn |
| Mar 31, 2026 | -3.97 Mn |
| Dec 31, 2025 | -4.67 Mn |
| Sep 30, 2025 | -7.09 Mn |
| Jun 30, 2025 | -4.44 Mn |
| Mar 31, 2025 | -3.75 Mn |
| Dec 31, 2024 | -3.76 Mn |
| Sep 30, 2024 | -5.03 Mn |
| Jun 30, 2024 | -2.97 Mn |
| Mar 31, 2024 | -3.36 Mn |
| Dec 31, 2023 | -5.38 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Jun 30, 2023 | -5.01 Mn |
| Mar 31, 2023 | -8.34 Mn |
| Dec 31, 2022 | -14.40 Mn |
| Sep 30, 2022 | -8.44 Mn |
| Jun 30, 2022 | -16.68 Mn |
| Mar 31, 2022 | -17.33 Mn |
| Dec 31, 2021 | -7.05 Mn |
| Sep 30, 2021 | -7.18 Mn |